SELL
L-selectin
Also known as: CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, LYAM1_HUMAN, PLNHR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P14151
- Gene
- SELL
- Ensembl
- ENSG00000188404
- Chromosome
- 1
- Canonical length
- 372 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors. The encoded protein contains a C-type lectin-like domain, a calcium-binding epidermal growth factor-like domain, and two short complement-like repeats. The gene product is required for binding and subsequent rolling of leucocytes on endothelial cells, facilitating their migration into secondary lymphoid organs and inflammation sites. Single-nucleotide polymorphisms in this gene have been associated with various diseases including immunoglobulin A nephropathy. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
372 residues, UniProt reviewed canonical sequence.
>P14151|SELL
1 MIFPWKCQST QRDLWNIFKL WGWTMLCCDF LAHHGTDCWT YHYSEKPMNW QRARRFCRDN
61 YTDLVAIQNK AEIEYLEKTL PFSRSYYWIG IRKIGGIWTW VGTNKSLTEE AENWGDGEPN
121 NKKNKEDCVE IYIKRNKDAG KWNDDACHKL KAALCYTASC QPWSCSGHGE CVEIINNYTC
181 NCDVGYYGPQ CQFVIQCEPL EAPELGTMDC THPLGNFSFS SQCAFSCSEG TNLTGIEETT
241 CGPFGNWSSP EPTCQVIQCE PLSAPDLGIM NCSHPLASFS FTSACTFICS EGTELIGKKK
301 TICESSGIWS NPSPICQKLD KSFSMIKEGD YNPLFIPVAV MVTAFSGLAF IIWLARRLKK
361 GKKSKRSMND PYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SELL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 217 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 217 nTPM
- tonsil: 189 nTPM
- spleen: 157 nTPM
- bone marrow: 142 nTPM
- thymus: 123 nTPM
- appendix: 112 nTPM
Single-cell type
- neutrophils: 1,391 nCPM
- pdcs: 301 nCPM
- thymocytes: 190 nCPM
- hematopoietic stem cells: 184 nCPM
- neutrophil progenitors: 181 nCPM
- b-cells: 166 nCPM
Immune cell
- neutrophil: 4,214 nTPM
- basophil: 3,697 nTPM
- NK-cell: 2,559 nTPM
- total PBMC: 2,050 nTPM
- eosinophil: 1,700 nTPM
- naive CD4 T-cell: 1,173 nTPM
Brain region
- cerebellum: 15 nTPM
- white matter: 13 nTPM
- medulla oblongata: 13 nTPM
- cerebral cortex: 11 nTPM
- spinal cord: 11 nTPM
- pons: 6.9 nTPM
ReferencesPubMed · IEDB
Publications for SELL from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice.
1994 · Proc Natl Acad Sci U S A · RCR 1.8 · 91 citations - Cell adhesion molecules: a selective therapeutic target for alleviation of IDDM.
1994 · J Autoimmun · RCR 0.2 · 8 citations - L-selectin-specific autoantibodies in murine lupus: possible involvement in abnormal homing and polarization of CD4+ T cell subsets.
1998 · J Immunol · RCR 0.1 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell adhesion
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- leukocyte cell-cell adhesion
- leukocyte tethering or rolling
- response to cytokine
Molecular functions
- calcium ion binding
- carbohydrate binding
- glycosphingolipid binding
- heparin binding
- oligosaccharide binding
- protease binding
- sialic acid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sushi/SCR/CCP domain
- EGF-like domain
- C-type lectin-like
- Selectin superfamily
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- C-type lectin, conserved site
- Selectin, C-type lectin-like domain
- Sushi/SCR/CCP superfamily
- Complement & Cell Adhesion Regulators
- EGF-like domain
- Lectin C-type domain
- Sushi repeat (SCR repeat)
- L-selectin
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SELL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SELL as an antibody target. Whether an autoantibody or antibody against SELL could matter depends on whether native SELL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SELL is annotated at the cell surface, where native SELL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SELL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...